InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: dia76ca post# 16543

Thursday, 03/19/2020 7:29:44 PM

Thursday, March 19, 2020 7:29:44 PM

Post# of 16750
Next Thursday is the Q4 CC. I hope it will answer 3 questions.
1. When will we receive the translational data? Does the higher dose of Gen-1 result in higher levels of IL-12, interferon g, dendritic cells, memory T cells, and CD8+ and CD4+ in tumor? Does it increase the decrease in immunosuppressive biomarkers?
2. What is the FDA saying? Can we expect some form of expedited approval?
3. Is there partnering interest in Gen-1?....as there is in Thermodox? Might a large Pharma be interested in both?

"The refusal of the real is the number one dogma of our time" Rene Girard